It is a pharma private limited company based in Surat, Gujarat, India, established in 2020.
2020 | Surat, Gujarat, India | ActiveLewis Pharmaceuticals Private Limited, a active private limited company, was established on 23 January 2020 in Surat, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290GJ2020PTC112260. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
Its leadership includes Jignesh Karsanbhai Solanki (Director), Umang Rajendrakumar Patel (Director). It holds ₹9.95 M open charges and ₹1.50 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 13, Bhagvati Park Society, Honey Park Road, Adajan,, Surat, Gujarat, 395007.
U24290GJ2020PTC112260
112260
23 January 2020
₹1.50 M
₹1.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Lewis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jignesh Karsanbhai Solanki | Director | 23 Jan 2020 | Current |
| Umang Rajendrakumar Patel | Director | 23 Jan 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lewis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.73% increase. The company also saw a substantial improvement in profitability, with a 168.03% increase in profit. The company's net worth Soared by an impressive increase of 72.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Lewis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹9,950,000.00
₹15,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jun 2025 | Axis Bank Limited | ₹9.95 M | Open |
| 27 Jan 2024 | Axis Bank Limited | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lewis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lewis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lewis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lewis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
A charge with Axis Bank Limited amounted to Rs. 9.95 M with Charge ID 101118650 was registered on 18 Jun 2025. was recorded as a recent event.
Progress on Lewis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
A charge registered on 27 Jan 2024 via Charge ID 100865931 with Axis Bank Limited was fully satisfied on 05 Mar 2025. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 15.00 M with Charge ID 100865931 was registered on 27 Jan 2024. was completed.
The activity Jignesh Karsanbhai Solanki was appointed as a Director was appointed as a Director on 23 Jan 2020 & has been associated with this company since 5 years 11 months . was completed.
The CIN of Lewis Pharmaceuticals Private Limited is U24290GJ2020PTC112260.
Lewis Pharmaceuticals Private Limited is headquartered at Plot No. 13, Bhagvati Park Society, Honey Park Road, Adajan,, Surat, Gujarat, 395007.
Lewis Pharmaceuticals Private Limited was incorporated on 23 January 2020.
The current directors of Lewis Pharmaceuticals Private Limited are
The primary industry of Lewis Pharmaceuticals Private Limited is Trade.
Lewis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Lewis Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX